Zepp Health Corporation
ZEPP
$2.56
$0.000.00%
NYSE
| 09/30/2024 | 03/31/2024 | 12/31/2023 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -48.91% | -57.57% | -44.93% | -44.93% | -52.82% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -48.91% | -57.57% | -44.93% | -44.93% | -52.82% |
| Cost of Revenue | -54.10% | -68.10% | -54.68% | -54.68% | -61.43% |
| Gross Profit | -38.78% | -2.08% | -7.59% | -7.59% | -16.42% |
| SG&A Expenses | 15.20% | -13.54% | -32.18% | -32.18% | -36.33% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -32.71% | -52.00% | -48.81% | -48.81% | -56.26% |
| Operating Income | -1,009.14% | 28.17% | 107.40% | 107.40% | 112.88% |
| Income Before Tax | -4,093.67% | 37.95% | 114.75% | 114.75% | 104.47% |
| Income Tax Expenses | -- | 101.98% | 887.97% | 887.97% | 101.34% |
| Earnings from Continuing Operations | -5,084.59% | 26.39% | 89.18% | 89.18% | 110.57% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -70.37% | 13.38% | -154.01% | -154.01% | 45.16% |
| Net Income | -4,622.53% | 26.45% | 89.02% | 89.02% | 111.73% |
| EBIT | -1,009.14% | 28.17% | 107.40% | 107.40% | 112.88% |
| EBITDA | -412.82% | 29.97% | 133.13% | 133.13% | 138.46% |
| EPS Basic | -4,351.30% | 30.52% | 88.86% | 88.89% | 111.84% |
| Normalized Basic EPS | -2,892.47% | 34.33% | 121.66% | 121.65% | 107.22% |
| EPS Diluted | -5,228.13% | 30.23% | 88.92% | 88.95% | 109.78% |
| Normalized Diluted EPS | -3,051.14% | 34.33% | 121.66% | 121.65% | 106.83% |
| Average Basic Shares Outstanding | 6.27% | 5.87% | -1.36% | -1.36% | -0.80% |
| Average Diluted Shares Outstanding | 0.88% | 5.87% | -1.36% | -1.36% | 4.50% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |